Deep Knowledge Analytics is the leading DeepTech-focused analytical agency, producing advanced analytical reports on DeepTech and frontier-technology industries using sophisticated multi-dimensional analytical frameworks and algorithmic methods that combine hundreds of specially-designed and specifically-weighted metrics and parameters to deliver sophisticated market intelligence, pragmatic forecasting and tangible industry benchmarking.


It is an analytical subsidiary of Deep Knowledge Ventures, a data-driven investment fund focused on the synergetic convergence of DeepTech and frontier technologies at the nexus of technological megatrends, renowned for its use of sophisticated analytical systems for investment target identification and due-diligence. Major investment sectors include AI, Precision Medicine, Longevity, Blockchain and InvestTech. While its major short-term interests are AI and DeepTech, it’s long term vision is focused on Longevity and Precision Health.


Cooperation with Government-Related Organizations

Deep Knowledge Analytics specializes in conducting special case studies and producing advanced industry analytical reports on the topics of Artificial Intelligence, GovTech, Blockchain, FinTech and Invest-Tech. It has produced a number of comprehensive analytical reports in coordination with the UK All-Parties Parliamentary Groups on AI and on Blockchain, including its AI in UK Landscape Overview 2018 and Blockchain in UK Landscape Overview 2018, unprecedented in their scope and length, and collectively more than 3000 pages. The company has also recently deployed advanced interactive online IT-platforms that feature dynamic mindmaps and filterable, customizable databases updated with new industry developments in real-time.


Pharma Division of Deep Knowledge Analytics

In 2018, Deep Knowledge Analytics aggregated its industry intelligence relating to AI in Drug Discovery, Pharma and Advanced Healthcare under the umbrella of a new Pharma Division of Deep Know, which has since become the dominating analytics entity in this field, publishing multiple open-source reports with the aim of accelerating the development of the sector and improve the implementation of AI in Pharma in particular, as well as a number of specialized proprietary analytical reports for its corporate clients and strategic partners. The Pharma Division of Deep Knowledge Analytics is the leading analytical entity specifically focused on deep intelligence of the pharma industry and the AI for Drug Discovery sector. Its reports have been covered by top-tier tech, business and finance media including Forbes, Financial Times, acknowledged by many other authoritative entities such as MIT Review. Its reports have been recognized by industry experts and executives as the dominant source of sophisticated industry analysis, pragmatic forecasting and tangible benchmarking on the AI in Pharma sector. The Pharma Division of Deep Knowledge Analytics currently serves as the main source of market intelligence and analytics for AI-Pharma, a specialized hybrid hedge fund.


IT-Department of Deep Knowledge Analytics

In 2019, the IT-department of Deep Knowledge Analytics releasing an advanced online Analytics Platform and database featuring interactive visuals which can transform static analytical reports on the topics of the AI, AI for Drug Discovery and Longevity industries into dynamic infographics updated in real-time. This platform will enable complex interactions between industry entities and stakeholders to be visualized, filtered, searched and thus more easily understood. The platform will enable low-cost and high-speed access to bespoke online live reporting on developments in  the technology and industrial ecosystems of the AI, Longevity, AI for Drug Discovery sectors, with confidence that the data and analytics are of high accuracy, available 24/7 and up to date.


Aging Analytics Agency

Deep Knowledge Analytics works closely with its strategic partner Aging Analytics Agency, the Longevity-focused analytical subsidiary of Deep Knowledge Ventures and the world’s premier provider of public and proprietary industry analytics on the topics of Longevity, Precision Preventive Medicine and Economics of Ageing, and the convergence of technologies such as AI and Digital Health and their impact on the healthcare industry. The company provides strategic consulting services in fields related to Longevity, and currently serves as the primary source of analytics for the specialized index hedge fund Longevity.Capital, as well as the UK All-Party Parliamentary Group for Longevity. Whereas previously it was focused on specific sectors of biomedicine industry and scientific/technological domains related to Longevity, in response to beginning to work with several Government-related organizations globally and to recent enhancements to its executive management team (such as the appointment of Eric Kihlstrom, former Director of the UK Government-led £98 Healthy Ageing Industrial Strategy Challenge Fund, as its new director), the agency has begun to focus significant resources to the production of sophisticated open-access and proprietary analytics on the topics of Longevity Governance and Governmental Development Plans (with its most recent report on this topic having been presented in UK Parliament at the APPG for Longevity launch), and to the intersection of Longevity and Advancing Financial Industry of Pension Funds and Insurance Companies, and the global multi-trillion opportunity of financial instruments and derivatives related to so-called “Longevity Risk”.

Future Prospects

Deep Knowledge Analytics will continue to expand the scope, depth and topics covered by its analytical reports on frontier technology-driven industries, with the aim to develop the next iterations of their analytical frameworks with a wider breadth and depth of metrics and overall analytics, to apply efficient methods to cross-sector analysis between different industries, and to apply both existing and new analytical frameworks to the design of the new Invest-Tech solutions (novel investment technologies and strategies relevant for the third decade of the twenty-first century), which is the only relevant way to implement the long-term strategic vision of Deep Knowledge Ventures.

NeuroTech Analytics

NeuroTech Analytics specializes in the production of open-access and commercial comparative analytics on the full scope of the global NeuroTech industry, ranging from brain-computer interfaces to implant technologies, neurostimulation and neuromodulation, and neuroplasticity-increasing apps.